June 2005

Marler Clark, Food Poisoning Lawyers

Marler Clark is the nation’s foremost law firm with a practice dedicated to representing victims of food poisoning.

Since 1993, Marler Clark’s lawyers have represented thousands of clients in litigation against restaurants and food companies whose food was traced as the source of illness. The Marler Clark food poisoning lawyers…

For more information see:
www.about-shigella.com
Shigella is a genus of bacteria that can cause sudden and severe diarrhea (gastroenteritis) in humans. Shigella thrives in the human intestine and is commonly spread both through food and by person-to-person contact. A Japanese scientist Kiyoshi Shiga discovered these bacteria over 100 years ago. Shigellosis is the name of the disease that Shigella causes. The illness is also known as “bacillary dysentery.”
Where does Shigella come from?Continue Reading What is Shigella?

LEXINGTON, KY
June 3, 2005
Twenty-two cases of bacterial dysentery, also known as shigellosis, have been reported to the Lexington-Fayette County Health Department since May 26.
Officials with the Health Department have notified physicians in Fayette County of the outbreak.
The disease is caused when people ingest water, food, or other materials contaminated by bacteria found in human feces. Symptoms include diarrhea, fever, nausea, vomiting, and cramps. Young children are likely to develop severe symptoms faster than adults.Continue Reading Physicians Notified After Outbreak Of Shigellosis Reported

Medical Research News
Friday, 3-Jun-2005
Scientists at the Albert Einstein College of Medicine have discovered a novel strategy by which the bacterium that causes tuberculosis may soon be able to resist the effects of antibiotics known as fluoroquinolones. The finding explains why several disease-causing microbes, including Shigella and E. coli, are rapidly becoming resistant to fluoroquinolones.
The international research effort was led by Dr. John S. Blanchard, the Dan Danciger Professor of Biochemistry at the Albert Einstein College of Medicine. The findings are published in the June 3 issue of Science.
Fluoroquinolones, an important class of antibiotics that includes ciprofloxacin (Cipro), work against TB by interfering with the microbe’s ability to reproduce itself. Specifically, the drugs target an enzyme called DNA gyrase, which helps untwist bacterial DNA during replication. However, TB has been developing resistance to fluoroquinolones due to their increasing use in treating multi-drug-resistant TB infections.Continue Reading Research explains why Shigella and E. coli are rapidly becoming resistant to fluoroquinolones